NASDAQ:MIRA MIRA Pharmaceuticals (MIRA) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free MIRA Stock Alerts $0.86 -0.04 (-4.45%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.85▼$0.9250-Day Range$0.79▼$1.5752-Week Range$0.76▼$7.98Volume12,549 shsAverage Volume553,535 shsMarket Capitalization$12.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get MIRA Pharmaceuticals alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About MIRA Pharmaceuticals Stock (NASDAQ:MIRA)MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.Read More MIRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MIRA Stock News HeadlinesApril 17, 2024 | msn.comMIRA Pharmaceuticals (MIRA) Price Target Decreased by 27.31% to 16.83April 2, 2024 | msn.comFDA clears first digital treatment for depression, but experts caution that research is still earlyApril 27, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 2, 2024 | marketwatch.comMIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2April 2, 2024 | markets.businessinsider.comMira Pharmaceuticals Steps Closer To Ketamir-2 IND Submission After Positive Preclinical ResultsApril 2, 2024 | finance.yahoo.comMIRA Making Strides Toward Breakthrough TreatmentApril 2, 2024 | prnewswire.comMira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND SubmissionMarch 28, 2024 | msn.com‘Ninja,’ Twitch’s biggest streamer, diagnosed with skin cancerApril 27, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 28, 2024 | msn.comClarence Thomas and Samuel Alito dust off 150-year-old Comstock Act to target abortion rightsMarch 21, 2024 | prnewswire.comMIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific AdvisorMarch 18, 2024 | ca.finance.yahoo.comThere are ways to improve the London Stock Exchange crisis, but they’re not prettyMarch 12, 2024 | finance.yahoo.comBaker Hill Nominated for Tech Company of the Year in TechPoint's 25th Annual Mira AwardsMarch 8, 2024 | msn.comALS drug fails large clinical trial and may be withdrawn from marketMarch 8, 2024 | msn.comMedical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update - Here's WhyMarch 8, 2024 | investorplace.comWhy Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today?March 1, 2024 | msn.comEl Salvador -India strengthen ties: Adriana Mira unveils path to bilateral cooperationFebruary 23, 2024 | ca.finance.yahoo.comMaternal mental health conditions drive climbing death rate in US, research saysFebruary 6, 2024 | finance.yahoo.comIs MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?February 5, 2024 | finanznachrichten.deMIRA Pharmaceuticals, Inc.: MIRA Pharmaceuticals Provides Corporate UpdateFebruary 5, 2024 | markets.businessinsider.comMIRA Pharmaceuticals Partners Pharmaseed To Conduct Pre-Clinical Studies On KetamirFebruary 5, 2024 | finance.yahoo.comMIRA Pharmaceuticals Provides Corporate UpdateJanuary 30, 2024 | finance.yahoo.comWearable Sensors Market Size Worth USD 11.05 Billion in 2032 | Emergen ResearchJanuary 29, 2024 | msn.comADHD medication recalled due to pill mixupDecember 20, 2023 | investing.comMira Pharmaceuticals (MIRA) Earnings Dates & ReportsDecember 18, 2023 | msn.comMIRA Pharmaceuticals files to sell up to 1.7M shares for holdersDecember 16, 2023 | seekingalpha.comIPO Update: Telomir Pharmaceuticals Proposes IPO TermsSee More Headlines Receive MIRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today4/26/2024Next Earnings (Estimated)7/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:MIRA Previous SymbolNASDAQ:MIRA CUSIPN/A CIK1904286 Webmirapharmaceuticals.com Phone737-289-0835FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio8.71 Quick Ratio8.71 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book2.87Miscellaneous Outstanding Shares14,780,000Free FloatN/AMarket Cap$12.71 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Erez Aminov (Age 45)CEO & Chairman Comp: $337.05kMs. Michelle Yanez M.B.A. (Age 51)CFO, Secretary & Treasurer Comp: $338.77kDr. Itzchak Angel Ph.D.Chief Scientific AdvisorKey CompetitorsPurple BiotechNASDAQ:PPBTRedHill BiopharmaNASDAQ:RDHLKiora PharmaceuticalsNASDAQ:KPRXImunonNASDAQ:IMNNTonix PharmaceuticalsNASDAQ:TNXPView All CompetitorsInsiders & InstitutionsPraetorian Wealth Management Inc.Bought 27,500 shares on 4/10/2024Ownership: 0.186%Brian Patrick McnultySold 46,005 sharesTotal: $71,307.75 ($1.55/share)Brian Patrick McnultySold 19,053 sharesTotal: $30,675.33 ($1.61/share)Brian Patrick McnultySold 27,733 sharesTotal: $81,812.35 ($2.95/share)Brian Patrick McnultySold 61,331 sharesTotal: $244,097.38 ($3.98/share)View All Insider TransactionsView All Institutional Transactions MIRA Stock Analysis - Frequently Asked Questions How have MIRA shares performed in 2024? MIRA Pharmaceuticals' stock was trading at $1.05 at the beginning of the year. Since then, MIRA stock has decreased by 18.1% and is now trading at $0.8598. View the best growth stocks for 2024 here. Are investors shorting MIRA Pharmaceuticals? MIRA Pharmaceuticals saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 42,300 shares, a decline of 26.4% from the March 31st total of 57,500 shares. Based on an average daily trading volume, of 670,400 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.4% of the company's shares are sold short. View MIRA Pharmaceuticals' Short Interest. When is MIRA Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024. View our MIRA earnings forecast. How were MIRA Pharmaceuticals' earnings last quarter? MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) announced its quarterly earnings results on Monday, April, 1st. The company reported ($0.19) earnings per share (EPS) for the quarter. When did MIRA Pharmaceuticals IPO? MIRA Pharmaceuticals (MIRA) raised $9 million in an initial public offering on Thursday, August 3rd 2023. The company issued 1,275,000 shares at a price of $7.00 per share. Who are MIRA Pharmaceuticals' major shareholders? MIRA Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Praetorian Wealth Management Inc. (0.19%). Insiders that own company stock include Brian Patrick Mcnulty and George Cappy. View institutional ownership trends. How do I buy shares of MIRA Pharmaceuticals? Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MIRA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
